🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 21 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/04/2023 | 137,24 | 138,96 | 135,89 | 137,55 | -0,20% | 2,24% | 798.500 |
| 31/03/2023 | 137,38 | 139,18 | 136,73 | 137,83 | +1,32% | 1,78% | 1.244.400 |
| 30/03/2023 | 136,66 | 137,64 | 134,04 | 136,03 | -0,39% | 2,63% | 749.800 |
| 29/03/2023 | 135,50 | 137,63 | 134,79 | 136,56 | +1,99% | 2,10% | 1.184.600 |
| 28/03/2023 | 131,62 | 134,62 | 131,08 | 133,90 | +2,10% | 2,69% | 973.900 |
| 27/03/2023 | 131,51 | 132,24 | 129,41 | 131,14 | +0,73% | 2,15% | 981.500 |
| 24/03/2023 | 128,97 | 130,54 | 126,99 | 130,19 | +1,41% | 2,75% | 969.100 |
| 23/03/2023 | 130,20 | 131,12 | 125,67 | 128,38 | -0,57% | 4,19% | 991.300 |
| 22/03/2023 | 131,94 | 131,94 | 128,71 | 129,11 | -1,57% | 2,45% | 1.677.800 |
| 21/03/2023 | 132,68 | 137,09 | 130,45 | 131,17 | -0,16% | 5,00% | 2.109.600 |
| 20/03/2023 | 123,89 | 131,77 | 123,30 | 131,38 | +7,08% | 6,84% | 2.688.800 |
| 17/03/2023 | 119,31 | 125,08 | 117,11 | 122,69 | -18,03% | 6,68% | 7.412.700 |
| 16/03/2023 | 145,51 | 150,81 | 143,75 | 149,67 | +2,89% | 4,85% | 1.913.500 |
| 15/03/2023 | 143,84 | 145,81 | 142,86 | 145,47 | +0,39% | 2,05% | 1.029.600 |
| 14/03/2023 | 143,81 | 148,26 | 143,73 | 144,90 | +1,49% | 3,15% | 1.214.100 |
| 13/03/2023 | 143,04 | 149,00 | 142,21 | 142,77 | -0,80% | 4,75% | 1.202.500 |
| 10/03/2023 | 148,45 | 148,50 | 141,00 | 143,92 | -3,05% | 5,05% | 1.815.500 |
| 09/03/2023 | 152,35 | 153,79 | 146,86 | 148,44 | -2,96% | 4,55% | 2.179.400 |
| 08/03/2023 | 155,36 | 155,87 | 151,42 | 152,96 | -1,70% | 2,86% | 1.534.000 |
| 07/03/2023 | 156,66 | 158,20 | 154,54 | 155,61 | -0,24% | 2,34% | 1.122.300 |
| 06/03/2023 | 155,83 | 159,84 | 154,38 | 155,99 | +0,24% | 3,50% | 2.304.100 |
| 03/03/2023 | 150,03 | 157,00 | 148,51 | 155,61 | +1,71% | 5,66% | 3.174.000 |
| 02/03/2023 | 145,00 | 153,92 | 144,49 | 153,00 | +5,06% | 6,50% | 3.142.800 |
| 01/03/2023 | 144,00 | 152,30 | 143,00 | 145,63 | +19,24% | 6,46% | 7.074.100 |
| 28/02/2023 | 118,04 | 122,38 | 117,90 | 122,13 | +3,39% | 3,80% | 1.634.200 |
| 27/02/2023 | 123,48 | 125,51 | 117,25 | 118,13 | -4,01% | 6,69% | 1.837.600 |
| 24/02/2023 | 123,53 | 126,71 | 122,43 | 123,06 | -1,41% | 3,46% | 793.400 |
| 23/02/2023 | 127,02 | 127,57 | 124,33 | 124,82 | -1,32% | 2,55% | 555.800 |
| 22/02/2023 | 122,12 | 126,83 | 122,00 | 126,49 | +3,76% | 3,96% | 771.000 |
| 21/02/2023 | 124,19 | 124,58 | 121,83 | 121,91 | -2,14% | 2,21% | 1.088.100 |